We will be partnering at The BIO International Convention 2024
We are excited to be attending the BIO International Convention 2024, 3rd - 6th June 2024.
We are excited to be attending the BIO International Convention 2024, 3rd - 6th June 2024.
Oxford University Innovation's Clinical Outcome team will be attending ISPOR 2024 in Atlanta, Georgia from the 5th - 8th May 2024.
Oxford University Innovation's Clinical Outcome team will be attending BioTrinity 2024 conference in London, UK on the 23-24th April 2024.
Oxford University Innovation announces the much-anticipated relaunch of the Oxford Innovation Society (OIS). With an ambitious 12-month programme of events, OIS aims to fortify connections between Oxford’s companies, investors, industry partners and the vibrant Oxford entrepreneurial ecosystem.
OUI’s Diabetes Health Profiles empower those living with diabetes to have a voice in their healthcare.
Available to licence through Oxford University Innovation’s Clinical Outcomes team.
Now available to licence through Oxford University Innovation’s Clinical Outcomes team.
Oxford University Innovation's Clinical Outcome team will be attending and presenting at the annual ISOQOL 2023 conference in Calgary, Canada from the 18th - 21st October 2023.
The GCA-PRO is a validated outcome measure for use in clinical trials, observation studies and clinical practice. It can also be used as a communication tool between patients and their clinicians, to highlight areas of greatest importance to patients, within face to face or online consultations.